Literature DB >> 11891959

T stage as prognostic factor in irradiated localized squamous cell carcinoma of the nasal vestibule.

Eelco Kummer1, Coen R N Rasch, Ronald B Keus, I Bing Tan, Alfons J M Balm.   

Abstract

BACKGROUND: To investigate the impact of T stage according to Wang on the prognosis of irradiated nasal vestibule carcinoma. PATIENTS AND METHODS: Treatment results of 47 patients were retrospectively analyzed. Treatment consisted of external beam radiotherapy (n = 26) or interstitial radiotherapy (n = 19) or a combination of both (n = 2) for a primary, localized, squamous cell carcinoma of the nasal vestibule. Mean follow-up was 5 years and 7 months.
RESULTS: T1/T2 tumors: Local control was achieved in 40 of 44 patients; surgical salvage was possible in 2 of 4 local failures. Five patients had recurrences in the neck, and four of them could be salvaged surgically. One patient had distant metastases develop. T3 tumors (n = 3): no T3 tumor could locally be cured by radiotherapy. One patient was salvaged surgically but died of regional and distant metastases. Disease-specific survival is significantly correlated with T stage according to Wang (p =.0001). Most (85%) patients were smokers, and eight of them (20%) had a second primary tumor develop in the lungs.
CONCLUSIONS: The effect of radiotherapy is significantly correlated with T stage (p =.0001) and hence less successful in T3 lesions as primary treatment option. The high incidence of second primary tumors in the lung is indicative for a similar carcinogenic influence of smoking on the nasal vestibule. Copyright 2002 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2002        PMID: 11891959     DOI: 10.1002/hed.10023

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  6 in total

1.  Radiation therapy for nasal vestibule squamous cell carcinoma: a 40-year experience.

Authors:  Justin Wray; Christopher G Morris; Jessica M Kirwan; Robert J Amdur; John W Werning; Peter T Dziegielewski; William M Mendenhall
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-03-13       Impact factor: 2.503

2.  Local control and intermediate-term cosmetic outcome following IMRT for nasal tumors : An update.

Authors:  Yuki Mukai; Stefan Janssen; Christoph Glanzmann; David Holzmann; Gabriela Studer
Journal:  Strahlenther Onkol       Date:  2016-12-05       Impact factor: 3.621

3.  The presence of aberrant p53 pattern is a negative prognostic predictor in squamous cell carcinoma of the nasal vestibule.

Authors:  Domenic Vital; Gerhard F Huber; David Holzmann; Holger Moch; Kristian Ikenberg
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-07-01       Impact factor: 2.503

4.  Interventional radiotherapy as exclusive treatment for primary nasal vestibule cancer: single-institution experience.

Authors:  Luca Tagliaferri; Nadia Carra; Valentina Lancellotta; Davide Rizzo; Calogero Casà; Giancarlo Mattiucci; Claudio Parrilla; Bruno Fionda; Francesco Deodato; Patrizia Cornacchione; Maria Antonietta Gambacorta; Gaetano Paludetti; Vincenzo Valentini; Francesco Bussu
Journal:  J Contemp Brachytherapy       Date:  2020-10-30

5.  Synchronous double primary cancer of the lung and nasal vestibule: A case report and literature review.

Authors:  Huai Jun Ji; Q I Zang; Wei Wang; Ning Bo Sun; Ming Cao; Qiang Zhu; Zhong Min Jiang
Journal:  Mol Clin Oncol       Date:  2016-03-03

6.  Carbon Ion Beam Boost Irradiation in Malignant Tumors of the Nasal Vestibule and the Anterior Nasal Cavity as an Organ-Preserving Therapy.

Authors:  Fabian Eberle; Rita Engenhart-Cabillic; Markus M Schymalla; Christoph Dumke; Ulrike Schötz; Florentine S B Subtil; Kilian-Simon Baumann; Boris A Stuck; Christine Langer; Alexandra D Jensen; Henrik Hauswald; Stefan Lautenschläger
Journal:  Front Oncol       Date:  2022-02-15       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.